We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccination of children and young people aged 5 to 11 years and booster vaccinations in those aged 12 to 17 years.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) about increasing the short-term impact of the COVID-19 vaccination programme.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the benefits of a third primary COVID-19 vaccine dose in individuals aged 12 years and over with severe immunosuppression.
Updated statement from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccination of children and young people aged 12 to 17 years
Updated advice from the Joint Committee on Vaccination and Immunisation (JCVI) on vaccination of children aged 12 to 15.
Statement setting out advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 vaccination programme for spring 2024 and beyond.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccination in children and young people aged 16 to 17 years.
Interim advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the coronavirus (COVID-19) autumn booster programme for 2022.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the effectiveness of the COVID-19 booster vaccination programme on the Omicron variant.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on a COVID-19 booster vaccine programme for winter 2021 to 2022.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccination of children and young people aged 12 to 17 years
Statement from the Joint Committee on Vaccination and Immunisation on vaccinating children aged 5 to 11.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the coronavirus (COVID-19) autumn booster programme for 2022.
Statement setting out the advice from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccination for children aged 6 months to 4 years.
Final statement from the Joint Committee on Vaccines and Immunisation (JCVI) on the groups that should be prioritised for vaccination in phase 2 of the programme.
Statement setting out the interim advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 vaccination programme for 2023.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the use of the AstraZeneca COVID-19 vaccine.
Updated advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 booster vaccine programme for winter 2021 to 2022.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) in response to the emergence of the Omicron variant.
The Joint Committee on Vaccination and Immunisation's (JCVI) statement on delivery of the human papillomavirus (HPV) programme in light of school closures associated with coronavirus (COVID-19).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).